World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
36462
World Ranking
15878
National Ranking
516

Overview

Franck Carbonnel is affiliated with the University of Paris-Saclay in France. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on subfields such as Genetics, Epidemiology, Surgery, Public Health, Environmental and Occupational Health, and Oncology.

The scientist's work concentrates primarily on topics including Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Cancer Immunotherapy and Biomarkers, Nutritional Studies and Diet, Pregnancy and Medication Impact, and Autoimmune and Inflammatory Disorders.

Frequent co-authors collaborating with Franck Carbonnel include:

  • Antoine Meyer
  • Aurélien Amiot
  • Matthieu Allez
  • Yoram Bouhnik
  • Julien Kirchgesner

The scientist has published extensively in a number of peer-reviewed venues, with the most frequent publication forums being:

  • Alimentary Pharmacology & Therapeutics
  • Journal of Crohn's and Colitis
  • Clinical Gastroenterology and Hepatology
  • Digestive and Liver Disease
  • Clinics and Research in Hepatology and Gastroenterology

Significant recent papers authored or co-authored by Franck Carbonnel include:

  • Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer, 2020, Nature Communications
  • The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor, 2020, Alimentary Pharmacology & Therapeutics
  • Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease, 2020, Alimentary Pharmacology & Therapeutics
  • Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, 2023, Clinical Gastroenterology and Hepatology

Best Publications

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage

  • Immune-related adverse events with immune checkpoint blockade: a comprehensive review

    J.M. Michot;C. Bigenwald;S. Champiat;M. Collins

  • Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. B. A. G. Haanen;F. Carbonnel;C. Robert;K. M. Kerr

  • Long-term evolution of disease behavior of Crohn's disease.

    Jacques Cosnes;Stéphane Cattan;Antoine Blain;Laurent Beaugerie

  • Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

    N. Chaput;P. Lepage;C. Coutzac;C. Coutzac;E. Soularue;E. Soularue

  • Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

    Celine Boutros;Ahmad Tarhini;Emilie Routier;Olivier Lambotte

  • Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

    S. Champiat;S. Champiat;O. Lambotte;E. Barreau;R. Belkhir

  • The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease

    Marcus Harbord;Vito Annese;Stephan R. Vavricka;Matthieu Allez

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez

  • Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

    Magali Lemaitre;Julien Kirchgesner;Annie Rudnichi;Fabrice Carrat

  • Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

    Julien Kirchgesner;Magali Lemaitre;Fabrice Carrat;Mahmoud Zureik

  • Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

    P. Marteau;M. Lémann;P. Seksik;D. Laharie

  • Smoking cessation and the course of Crohn's disease: an intervention study.

    Jacques Cosnes;Laurent Beaugerie;Franck Carbonnel;Jean–Pierre Gendre

  • Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study

    Prévost Jantchou;Sophie Morois;Françoise Clavel-Chapelon;Marie-Christine Boutron-Ruault

  • Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.

    Clélia Coutzac;Jean Mehdi Jouniaux;Jean Mehdi Jouniaux;Angelo Paci;Angelo Paci;Julien Schmidt;Julien Schmidt

  • Corrections to “Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J.B.A.G. Haanen;F. Carbonnel;C. Robert;K.M. Kerr

  • The Role of Anatomic Factors in Nutritional Autonomy After Extensive Small Bowel Resection

    Franck Carbonnel;Jacques Cosnes;Sylvie Chevret;Laurent Beaugerie

  • Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.

    Franck Carbonnel;Anne Lavergne;Marc Lémann;Alain Bitoun

  • Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.

    L. Marthey;C. Mateus;C. Mussini;M. Nachury

  • Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial

    Jacques Cosnes;Anne Bourrier;David Laharie;Stéphane Nahon

Frequent Co-Authors

Marie-Christine Boutron-Ruault
Marie-Christine Boutron-Ruault University of Paris-Saclay
Anne Tjønneland
Anne Tjønneland University of Copenhagen
Antonia Trichopoulou
Antonia Trichopoulou National and Kapodistrian University of Athens
Yoram Bouhnik
Yoram Bouhnik Beaujon Hospital
Matthieu Allez
Matthieu Allez Université Paris Cité
Kim Overvad
Kim Overvad Aarhus University
Rudolf Kaaks
Rudolf Kaaks German Cancer Research Center
Heiner Boeing
Heiner Boeing German Institute of Human Nutrition
Petra H.M. Peeters
Petra H.M. Peeters Utrecht University
Rosario Tumino
Rosario Tumino Provincial Health Authority of Syracuse

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens numerous alternative and specialized career pathways beyond traditional medical school. Many students look into nursing and healthcare leadership roles that can be pursued through flexible online degree programs. For those seeking advanced clinical leadership, dnp programs online offer a way to earn a terminal nursing degree without pausing your career.

Cost is often a concern. By comparing the cheapest online dnp programs, you can find affordable options that still meet accreditation and quality standards. If you’re interested in quickly entering the healthcare workforce, an lpn accelerated program can allow you to become a licensed practical nurse in less time than traditional pathways.

Specializations are also in high demand. For example, the shortest pmhnp program makes it possible to launch a career as a psychiatric-mental health nurse practitioner quickly via online studies. These options provide flexible and efficient paths to meaningful work in healthcare without the lengthy commitments of standard medical school.

Best Scientists Citing Franck Carbonnel

Trending Scientists

Recently Published Articles